The Influence of Rheumatism on Health and Lifestyle<\/strong> (known natively in Dutch as the Invloed van Reuma op Gezondheid en Leefwijze<\/em>, abbreviated as IRGL<\/strong>) is a multidimensional, disease-specific self-report assessment tool designed to evaluate the physical, psychological, and social dimensions of health status in individuals diagnosed with chronic rheumatic disorders. Developed in the Netherlands by C. J. E. A. Huiskes, Floris W. Kraaimaat, and Johannes W. J. Bijlsma in 1990, the instrument was conceptualized partly as an adaptation and clinical extension of the Arthritis Impact Measurement Scales (AIMS)<\/a>, tailored specifically to capture the distinct illness trajectories, coping demands, and functional limitations characteristic of patients with chronic joint diseases such as rheumatoid arthritis<\/a>, osteoarthritis<\/a>, and ankylosing spondylitis<\/a>.<\/p>\n The IRGL comprises 16 overarching question clusters encompassing 68 discrete items organized across four principal health domains: physical functioning, psychological functioning, social functioning, and the overarching impact of rheumatic disease on daily life. A distinctive psychometric feature of the IRGL is its differential temporal framing: items assessing physical functioning refer to the patient's experiences over the preceding month, psychological functioning items encompass both the past week (affective states) and the past month (broader psychological well-being), and social functioning items evaluate interpersonal dynamics over the preceding six months. Responses are recorded on standardized Likert-type scales ranging from 4-point to 5-point formats. Extensive psychometric evaluations indicate high internal consistency across subscales (Cronbach\u2019s $\\alpha$<\/span> coefficients typically ranging from .70 to .92), satisfactory test-retest reliability across multi-week intervals, robust convergent validity with functional capacity measures such as the Health Assessment Questionnaire (HAQ), and demonstrable sensitivity to clinical change resulting from pharmacological and behavioral interventions.<\/p>\n Invloed van Reuma op Gezondheid en Leefwijze, IRGL, rheumatoid arthritis, health-related quality of life, psychometrics, physical functioning, psychological adjustment, social support, patient-reported outcome measures, biopsychosocial assessment<\/p>\n The IRGL was developed through a multidisciplinary collaboration between clinical psychologists and rheumatologists in the Netherlands:<\/p>\n Correspondence concerning the original development of the instrument historically centered at the Department of Rheumatology and Clinical Immunology, University Hospital Utrecht, and the Department of Clinical Psychology, Utrecht University, Netherlands.<\/p>\n Chronic rheumatic diseases represent a major etiology of persistent pain, progressive physical disability, emotional distress, and societal participation restriction worldwide. Traditional biomedical markers in rheumatology\u2014such as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), radiologic joint space narrowing, and joint counts\u2014frequently correlate only modestly with a patient's subjective experience of pain, daily functional impairment, and psychological distress. To bridge the gap between biological disease activity and the patient's lived experience, clinical researchers require validated patient-reported outcome measures (PROMs)<\/a> that capture health-related quality of life (HRQoL<\/a>) across multiple life spheres.<\/p>\n The primary purpose of the Influence of Rheumatism on Health and Lifestyle (IRGL)<\/strong> is to provide a standardized, psychometrically rigorous self-assessment profile of the physical, psychological, and social consequences of rheumatic illnesses. The instrument was deliberately constructed to overcome limitations observed in direct translations of foreign questionnaires, such as the original American Arthritis Impact Measurement Scales (AIMS). The developers identified that linguistic translation alone failed to account for Dutch healthcare structures, sociocultural norms surrounding independence, and specific communicative practices regarding chronic pain and social support.<\/p>\n Clinically, the IRGL serves several vital purposes:<\/p>\n The IRGL is conceptualized as an operationalization of multidimensional health status within the framework of chronic physical illness. Rather than yielding an oversimplified, unweighted composite score, the instrument posits that health status in chronic rheumatism consists of distinct, interrelated sub-constructs operating within physical, psychological, and social domains. Each domain is decomposed into specific, clinically grounded subscales:<\/p>\n Physical disability in rheumatic disease manifests across distinct biomechanical systems. The IRGL isolates these patterns into dedicated subscales, evaluated with reference to the preceding month:<\/p>\n Chronic unpredictable pain and impending functional decline evoke diverse affective reactions. The IRGL operationalizes psychological functioning not merely as the absence of psychopathology, but as an interplay between negative affectivity and positive psychological resources:<\/p>\n Recognizing that rheumatic disorders severely impact interpersonal relationships, role fulfillment, and community integration, the IRGL evaluates social constructs over a six-month recall interval:<\/p>\n In addition to functioning within traditional life spheres, the instrument captures disease-specific symptoms that directly influence lifestyle:<\/p>\n The design and conceptual architecture of the IRGL are grounded in three prominent theoretical paradigms: George Engel's Biopsychosocial Model<\/a>, Richard Lazarus and Susan Folkman's Transactional Theory of Stress and Coping<\/a>, and the functional disability frameworks codified by the World Health Organization<\/a>.<\/p>\n Historically, rheumatologic evaluation relied heavily on a biomedical reductionist framework, which assumed a direct, linear relationship between joint inflammation and clinical impairment. By contrast, the IRGL was engineered under the biopsychosocial premise that disease manifestation is modulated by complex, reciprocal interactions between biological variables (e.g., synovial inflammation, cartilage destruction), psychological factors (e.g., catastrophic interpretation of pain, affective vulnerability, perceived control), and social contexts (e.g., marital dynamics, workplace accommodations, social reinforcement of illness behaviors). Consequently, evaluating a patient's health requires independent yet concurrent quantification across physical, psychological, and social axes.<\/p>\n The IRGL draws heavily upon Lazarus and Folkman\u2019s conceptualization of stress as an ongoing transaction between the person and their environment. Chronic rheumatic conditions represent a continuous, unresolvable ambient stressor characterized by pain exacerbations (flares), functional fluctuations, and progressive somatic losses. Under this model:<\/p>\n The instrument aligns conceptually with the progression from impairment to disability and handicap, which formed the foundation of the original International Classification of Impairments, Disabilities, and Handicaps (ICIDH) and subsequent International Classification of Functioning, Disability and Health (ICF)<\/a>. The IRGL explicitly separates basic physical impairments (joint stiffness, fine motor limitations) from activity limitations (dressing, walking) and participation restrictions (social isolation, disruption of occupational roles), providing a coherent taxonomical framework for clinical analysis.<\/p>\n The validity of the IRGL has been thoroughly demonstrated across numerous psychometric investigations involving cohorts of patients with rheumatoid arthritis, osteoarthritis, fibromyalgia, and ankylosing spondylitis.<\/p>\n Construct validity has been established by demonstrating that the IRGL subscales correlate in predicted directions with established external reference standards:<\/p>\n Discriminant validity is supported by findings that the physical functioning subscales correlate substantially lower with psychological distress scales ($r = .18$<\/span> to $.32$<\/span>) than with objective mobility tests (e.g., timed walk tests). Conversely, biological markers of acute inflammation (ESR, CRP) correlate significantly with IRGL pain and physical function, but exhibit negligible correlations ($r < .15$) with the IRGL social support and positive affect subscales, demonstrating that the psychological and social subscales capture unique variance that cannot be explained by inflammatory activity alone.<\/p>\n Longitudinal prospective cohort studies led by researchers such as Evers, Kraaimaat, and colleagues (e.g., Evers et al., 1998, 2003) confirmed the predictive validity of the IRGL. Baseline scores on the IRGL psychological functioning subscales predicted long-term physical disability, subjective pain levels, and healthcare utilization at 1, 3, and 5 years post-diagnosis, after controlling for baseline disease activity and joint damage. Patients reporting higher initial anxiety and lower social support satisfaction demonstrated significantly poorer adaptation and accelerated functional decline over subsequent years.<\/p>\n The IRGL has undergone rigorous reliability testing in diverse patient populations across clinical and research settings in Western Europe.<\/p>\n Internal consistency has been repeatedly substantiated through the calculation of Cronbach\u2019s alpha ($\\alpha$<\/span>)<\/a> coefficients across independent validation samples. In the foundational standardization cohort of 244 rheumatoid arthritis patients reported by Huiskes et al. (1990):<\/p>\n Subsequent empirical investigations (e.g., Evers et al., 2003) utilizing large patient samples ($N > 400$<\/span>) reaffirmed these findings, with all core dimensions consistently meeting or exceeding the recommended psychometric threshold of $.70$<\/span> for group comparisons, and several key subscales exceeding $.85$<\/span>, rendering them sufficiently reliable for individual diagnostic tracking.<\/p>\n Test-retest stability was investigated across stable clinical intervals spanning 2 to 4 weeks among patients with medically stable rheumatoid arthritis. Intraclass correlation coefficients (ICCs) and Pearson correlation coefficients ranged from $.74$<\/span> to $.91$<\/span> across all subscales. The physical functioning and social network structural indices demonstrated the highest temporal stability ($r > .85$<\/span>), whereas the anxiety and pain subscales showed moderate fluctuations ($r = .72$<\/span> to $.80$<\/span>), appropriately capturing natural episodic symptom variation while maintaining strong underlying trait stability.<\/p>\n The structural dimensionality of the IRGL was established using both exploratory factor analysis (EFA)<\/a> during its initial scale construction and confirmed via confirmatory factor analysis (CFA)<\/a> in subsequent clinical populations.<\/p>\n Huiskes, Kraaimaat, and Bijlsma (1990) conducted principal component analyses (PCA) with oblimin (oblique) and varimax (orthogonal) rotations on item clusters derived from the Dutch adaptation of the AIMS alongside newly formulated items. The analysis consistently yielded clear, interpretable factor solutions reflecting distinct, lower-order functional dimensions rather than a single undifferentiated "illness severity" dimension:<\/p>\n Subsequent psychometric evaluations utilizing structural equation modeling (SEM) confirmed that a hierarchical, multi-factor model provides a significantly superior fit compared to unidimensional or simple three-factor (physical, psychological, social) models. When modeling a higher-order structure with physical, psychological, and social second-order factors subsuming their respective primary subscales, fit indices met standard criteria for adequate model fit:<\/p>\n These findings substantiate that while the subscales correlate within broad domains (e.g., Mobility and Self-Care sharing significant covariance), each subscale captures sufficient unique variance to warrant independent reporting and profile analysis.<\/p>\n The IRGL is structured as a comprehensive, standardized, pencil-and-paper or digital self-administered questionnaire. Its structural parameters are outlined below:<\/p>\n The IRGL was originally published in 1990 by C. J. E. A. Huiskes, F. W. Kraaimaat, and J. W. J. Bijlsma in the Netherlands. The questionnaire, test manual, and scoring forms were distributed through academic and medical research channels, specifically affiliated with Utrecht University (Department of Clinical Psychology) and the University Medical Center Utrecht (Department of Rheumatology and Clinical Immunology).<\/p>\n The instrument, scoring instructions, and accompanying clinical guidelines are protected under academic copyright. However, for non-commercial academic research, epidemiologic investigations, and routine non-profit clinical practice, the IRGL is generally accessible upon request or through documented use in peer-reviewed scientific literature. Researchers and clinicians wishing to employ the IRGL in prospective clinical trials, commercial evaluations, or digital platforms must consult the copyright holders or academic successors at Utrecht University or Radboud University Nijmegen to secure formal permission and ensure use of the official, validated Dutch scoring algorithms.<\/p>\n Below are primary foundational references and key peer-reviewed empirical studies documenting the psychometric development, validation, and clinical application of the IRGL:<\/p>\nKeywords<\/h2>\n
Authors<\/h2>\n
\n
Purpose<\/h2>\n
\n
Psychological Construct<\/h2>\n
1. Physical Functioning Domain<\/h3>\n
\n
2. Psychological Functioning Domain<\/h3>\n
\n
3. Social Functioning Domain<\/h3>\n
\n
4. Disease Impact and Pain<\/h3>\n
\n
Theoretical Framework<\/h2>\n
The Biopsychosocial Paradigm<\/h3>\n
Transactional Stress and Coping Theory<\/h3>\n
\n
Integration with Disability Classifications<\/h3>\n
Validity<\/h2>\n
Construct and Convergent Validity<\/h3>\n
\n
Discriminant Validity<\/h3>\n
Predictive and Longitudinal Validity<\/h3>\n
Reliability<\/h2>\n
Internal Consistency<\/h3>\n
\n
Test-Retest Reliability<\/h3>\n
Factor Analysis<\/h2>\n
Exploratory Factor Structure<\/h3>\n
\n
Confirmatory Factor Analysis and Model Fit<\/h3>\n
\n
Instrument \/ Measurement Tool<\/h2>\n
\n
\n
\n
\n
Permissions & Fee and Test Year<\/h2>\n
References<\/h2>\n
\n
Items of the Scale<\/h2>\n